庄 李

庄 李


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2020 in Annals of Plastic Surgery
Verified
Journal Article
Closed access
BWBenjie Wang
Benjie Wang
LLLu Li
Lu Li
YWYikai Wang
Yikai Wang
ZWZihua Wang
Zihua Wang
庄李庄 李
庄 李
DZDeWei Zhao
DeWei Zhao
Introduction Nontraumatic osteonecrosis of the femoral head (NONFH) is a common and difficult disease in orthopedics. Magnetic resonance imaging (MRI) assessment of NONFH and bone marrow edema was combined with digital subtraction angiography (DSA) to evaluate the circulatory status of NONFH in different Association Research Circulation Osseous stages. Based on the circulatory obstruction status (venous stasis, arterial ischemia, and arterial occlusion), appropriate perioperative management was adopted to achieve hip joint preservation and effectively delay the time for total hip arthroplasty in young patients. Methods From January 2013 to March 2019, 41 orthopedic patients were evaluated for medical imaging. Sixty-one ONFH cases were enrolled. The inclusion criteria include: (1) Clear diagnosis of osteonecrosis of the femoral head. (2) No history of infection in the affected hip, no history of hip surgery, and no congenital hip diseases. The patients enrolled in this study were 8 women and 33 men between the ages of 19 and 64 years (mean, 39.25 +/- 8.90 years). Preoperative X-ray, computed tomography, MRI, DSA, and histological data were taken. Results The combination of DSA and MRI can efficiently show blood supply changes in the femoral head of NONFH patients at different Association Research Circulation Osseous stages; and also can possibly reveal the causes and development of NONFH. Different stages of circulatory obstruction of the femoral head can be clearly distinguished and used to determine the required perioperative management, thus yielding successful surgical outcomes. Conclusions The existing classification systems do not fully reflect the progression of circulatory obstruction in ONFH. Each stage of NONFH development has its own characteristics circulatory obstruction. Early-stage NONFH displays characteristic venous stasis of the femoral head, whereas advanced stage NONFH is characterized by insufficient arterial blood supply to the femoral head. Corresponding NONFH treatment strategies should be considered based on their specific circulatory status. This work also provides guidance and recommendations for adopting corresponding femoral head preserving strategies for young patients in different NONFH circulatory status.

9 September 2013 in World Journal of Surgical Oncology
Verified
Journal Article
Open access
PDF file
庄李庄 李
庄 李
YZYuewei Zhang
Yuewei Zhang
JZJun Zhou
Jun Zhou
GZGuangsheng Zhao
Guangsheng Zhao
STShunxiong Tang
Shunxiong Tang
Background: Colorectal cancer (CRC) is one of the most common cancers worldwide. The majority (approximately 60%) of patients with CRC will eventually develop liver metastases, which remain the most common cause of mortality in these patients. This study aimed to evaluate the therapeutic effect and tolerability of gelatin sponge particle (GSP)-mediated chemoembolization in the treatment of colorectal liver metastases after systemic chemotherapy failure. Methods: This was a single-center retrospective study of 15 patients with colorectal liver metastases, who underwent GSP-mediated chemoembolization with 50 mg of lobaplatin during the period December 2009 to December 2010 in the Department of Interventional Radiology, Affiliated Zhongshan Hospital of Dalian University. Clinical data were retrieved, and the therapeutic effect and tolerability of the treatment were evaluated. Results: All 15 patients with colorectal liver metastases completed the GSP-mediated chemoembolization. The therapeutic effect and tolerability were evaluated 3 months after the initial procedure. The tumor lesions in all patients showed various levels of necrosis and shrinkage. According to the Response Evaluation Criteria in Solid Tumors (RECIST), one patient achieved complete response (CR), eleven patients achieved partial response (PR), and three patients achieved stable disease (SD). The overall response rate (CR + PR) was 80%. Conclusions: GSP-mediated chemoembolization is well tolerated and has a good short-term response rate (80%) in the treatment of colorectal liver metastases after systemic chemotherapy failure. Collectively, further study of the long-term effect of GSP-mediated chemoembolization in colorectal liver metastasis in a large cohort is warranted.

21 May 2024 in Journal of Robotic Surgery
Verified
Journal Article
Closed access
PDF file
ZJZhe Ji
Zhe Ji
WZWang Zhe
Wang Zhe
YJYuliang Jiang
Yuliang Jiang
HSHaitao Sun
Haitao Sun
BQBin Qiu
Bin Qiu
JWJunjie Wang
Junjie Wang

26 March 2026 in Food and Chemical Toxicology
Verified
Journal Article
Closed access
YZYuwei Zhao
Yuwei Zhao
HQHao Qin
Hao Qin
WSWei Sun
Wei Sun
YCYu Chen
Yu Chen
RWRuoyu Wang
Ruoyu Wang
庄李庄 李
庄 李

6 November 2025 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
SCSongbai Chen
Songbai Chen
YKYunfeng Kou
Yunfeng Kou
YYYuting Yuan
Yuting Yuan
GZGuangsheng Zhao
Guangsheng Zhao
JZJun Zhou
Jun Zhou
庄李庄 李
庄 李
Objective: To evaluate the clinical efficacy, safety, and changes in the immune status of advanced non-small cell lung cancer (NSCLC) patients with disease progression after chemoradiotherapy treated with CT-guided 125 I radioactive seed implantation. Materials and methods: From January 2016 to June 2022, 34 NSCLC patients who progressed after radiotherapy and chemotherapy were studied retrospectively. There were 34 evaluable lesions, and 125 I seeds were implanted into the lesions under CT guidance. The study’s endpoints were as follows: short-term clinical efficacy, quality of life score, and adverse reaction status assessment, with patients being collected for immune status assessment. Results: The average postoperative follow-up period was 16.58 ± 7.41 months. The 1-year postoperative survival rate was 76.47% (26/34), the 2-year postoperative survival rate was 58.82% (20/34), and the median overall survival was 16 (6–24) months (95% CI: 13.7–18.3). The 1-year progression-free survival (PFS) rate after the operation was 61.76% (21/34), the 2-year PFS rate was 41.18% (14/34), and the median PFS was 12.5 (1–24) months (95% CI: 10.8–16.2). Postoperative pneumothorax occurred in 11.76% of patients, minor bleeding in 5.88%, and pneumonia in 2.94%, all of which improved after symptomatic treatment. Compared with the preoperative results, the percentages of CD3 + and CD4 + T lymphocytes in the treatment group increased 1, 2, 3, and 6 months after surgery; the percentage of NK cells increased 3 and 6 months after surgery. The positive immune factor levels of IL-2 and TNF-α were increased at 2, 3, and 6 months after surgery; γ-IFN levels were increased at 1, 2, 3, and 6 months after surgery; IL-4 levels were decreased at 3 and 6 months after surgery; and IL-10 levels were decreased at 6 months after surgery. TH17 (IL-17) levels decreased at 1, 2, 3, and 6 months after surgery. Conclusion: CT-guided 125 I particle therapy may be an effective treatment for NSCLC that has progressed following radiotherapy and chemotherapy. Local treatments improve patients’ quality of life and reduce tumor burden. CT-guided 125 I radioactive seed implantation may improve the immune status of patients with recurrent or progressive NSCLC after radiotherapy and chemotherapy and may enhance the antitumor immune response.

29 December 2022 in Brachytherapy
Verified
Journal Article
Closed access
SZShenghe Zhang
Shenghe Zhang
SCSongbai Chen
Songbai Chen
RWRuoyu Wang
Ruoyu Wang
ZWZhe Wang
Zhe Wang
JZJun Zhou
Jun Zhou
庄李庄 李
庄 李